Werner, Rudolf A.
Bundschuh, Ralph A.
Bundschuh, Lena
Javadi, Mehrbod S.
Higuchi, Takahiro
Weich, Alexander
Sheikhbahaei, Sara
Pienta, Kenneth J.
Buck, Andreas K.
Pomper, Martin G.
Gorin, Michael A.
Lapa, Constantin
Rowe, Steven P.
Funding for this research was provided by:
National Institutes of Health (CA134675, CA183031, CA184228, EB024495)
Prostate Cancer Foundation (N/A)
Horizon 2020 (701983)
Article History
Received: 6 August 2018
Accepted: 9 August 2018
First Online: 14 August 2018
Compliance with ethical standards
:
: MGP is a co-inventor on a United States Patent covering <sup>18</sup>F-DCFPyL and as such are entitled to a portion of any licensing fees and royalties generated by this technology. MAG has served as a consultant to Progenics Pharmaceuticals, the licensee of <sup>18</sup>F-DCFPyL. MAG and SPR have received research support from Progenics Pharmaceuticals.